Herring, W. Joseph

A Randomized, Placebo-Controlled, Crossover Pilot Trial of the Oral Selective NR2B Antagonist MK-0657 in Patients With Treatment-Resistant Major Depressive Disorder

Ibrahim, L., DiazGranados, N., Jolkovsky, L., Brutsche, N., Luckenbaugh, D. A., Herring, W. J., Potter, W. Z., & Zarate, C. A. (2012) · Journal of Clinical Psychopharmacology

Treatment of Major DepressionNeuroscience and Neuropharmacology Research

Cited by 220

The discovery of suvorexant, the first orexin receptor drug for insomnia

Coleman, P. J., Gotter, A. L., Herring, W. J., Winrow, C. J., & Renger, J. J. (2017) · Annual Review of Pharmacology and Toxicology

Sleep and Wakefulness ResearchSleep and related disorders

Cited by 128

Orexin receptor antagonists for the treatment of insomnia and potential treatment of other neuropsychiatric indications

Herring, W. J., Roth, T., Krystal, A. D., & Michelson, D. (2019) · Journal of Sleep Research

Sleep and related disordersSleep and Wakefulness Research

Cited by 53